Osteoarthritis Market Report include on MarketResearchFuture.com with exhaustive Study. The report aims to provide an overview of Osteoarthritis Market Report. The report provides key statistics on the market status. Global Forecast till 2023.
The Global Osteoarthritis Market is poised to capture a CAGR of approximately 6.8% over the forecast period of 2017-2023, proclaims Market Research Future (MRFR) in a minutely analyzed research report. The market is growing persistently on account of growing global geriatric population as it accounts for more disability among the elderly population than any other disease.
Elderly patients have been reported to experience radiographic osteoarthritis which increases as patients age. Rising populace of obesity is also considered to be the driving factor in the growth of the global osteoarthritis market since obesity has also been identified as a risk factor for osteoarthritis. Obesity reduces the skeletal-weight-to-body-mass which results in compressive forces to joints. Although the treatment market for osteoarthritis is not robust, increased prevalence of the disease has resulted in increased R&D activities which are expected to bring new treatment options to the market. Moreover, raising awareness about the disease may induce demand for medications and boost market growth. Low access to healthcare and the side effects of the treatment procedures are the most significant hurdles to the growth of the global osteoarthritis market. Stem cells treatments have been demonstrated as a possible treatment for osteoarthritis which is expected to provide growth opportunities to the global osteoarthritis market.
Get PDF Sample Copy of This Premium Report @ https://www.marketresearchfuture.com/sample_request/1609
Key Players
- Abbott. (U.S.),
- Novartis AG (Europe),
- Pfizer Inc. (U.S.),
- Eli Lilly and Company. (U.S.),
- ABIOGEN PHARMA S.p.A (Europe),
- Merck Sharp & Dohme Corp. (U.S.),
- TissueGene Inc. (U.S.),
- Ampio Pharmaceuticals Inc. (U.S.),
- Regeneron (U.S.), and others.
Segmentation
The global osteoarthritis market has been segmented based on type, diagnosis, treatment, and end users. By type, the osteoarthritis market has been segmented into hip osteoarthritis, wrist osteoarthritis, spinal osteoarthritis, and others.
By diagnosis, the osteoarthritis market has been segmented into imaging, joint fluid analysis, and others. The imaging segment, is sub-segmented into X-rays, magnetic resonance imaging (MRI), and others.
By treatment, the osteoarthritis has been segmented into medication, surgery, therapy, and others. The medication segment has been further segmented into analgesics and non-steroidal anti-inflammatory drugs, and others. The analgesic sub-segment has been further segmented into acetaminophen, duloxetine, and others. The non-steroidal anti-inflammatory drugs sub-segment has been further segmented into aspirin, ibuprofen, naproxen sodium and naproxen, and others.
By end users, the osteoarthritis segment has been hospitals & clinics, medical institutes, research organization, and others.
Regional Analysis
America dominates the Global Osteoarthritis Market owing to a well-developed healthcare sector and huge patient population for osteoarthritis. Apart from this, changing lifestyle and increasing healthcare expenditure have boosted the growth of the market in America
Europe is the second largest Osteoarthritis Market, which is followed by Asia Pacific. Availability of funds for research, huge patient population, increasing healthcare expenditures, well-developed healthcare sector and government support for research & development are projected to drive the market growth during the forecasted period.
Asia Pacific is the fastest growing region in Global the market due to the presence of a huge patient population, continuously developing economies like India and China, and presence of huge opportunity in the market. According to Indian Brand Equity Foundation in 2017, the Indian healthcare sector is one of the fastest growing industries and is expected to advance at a CAGR of 22.87% during the review period to reach USD 280 billion by 2020.
On the other hand, the Middle East & Africa holds the least share in the Global Osteoarthritis Market due to presence of poor economy, especially, in African region. Majority of the market of this region is held by the Middle East due to the well-developed healthcare sector and huge healthcare expenditure by the presence of economies like Kuwait, Saudi Arabia, Dubai and Qatar.
Browse Complete Report @ https://www.marketresearchfuture.com/reports/osteoarthritis-market-1609
Some Brief Table of Contents of Report
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porters Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
TOC Continued…
List of Tables
Table 1 Osteoarthritis Industry Synopsis, 2017 – 2023
Table 2 Global Osteoarthritis Market Estimates And Forecast, 2017 – 2023, (USD Million)
Table 3 Global Osteoarthritis Market By Region, 2017 – 2023, (USD Million)
Table 4 Global Osteoarthritis Market By Type, 2017 – 2023, (USD Million)
Table 5 Global Osteoarthritis Market By Diagnosis, 2017 – 2023, (USD Million)
Continued…
List of Figures
Figure 1 Research Process
Figure 2 Segmentation For Global Osteoarthritis Market
Figure 3 Market Dynamics For Global Osteoarthritis Market
Figure 4 Global Osteoarthritis Market Share, By Type 2016
Figure 5 Global Osteoarthritis Market Share, By Diagnosis 2016
Continued…
Do You Have Any Query? Ask to Our Experts @ https://www.marketresearchfuture.com/enquiry/1609
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Hadapsar, Pune – 411028
Maharashtra, India
Phone: +1 646 845 9312